← All Stemtech CORP filings

Stemtech CORP 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OTC.Pink
STEK
Stemtech CORP
8-K: Stemtech Corporation Announces CFO Transition: James Cardwell Resigns, Shrilakshmi Vadlapatla Appointed
Stemtech Corporation reports the resignation of CFO James Cardwell and the appointment of Shrilakshmi Vadlapatla as the new CFO, effective April 11, 2025.
OTC.Pink
STEK
Stemtech CORP
8-K: Stemtech Terminates Eevia Health RTO, Focuses on Viago Merger
Stemtech Corporation has ended its pursuit of a reverse takeover of Eevia Health Plc and is now concentrating on a merger with Viago, aiming for a listing on the Swedish MTF Nordic SME.
OTC.Pink
STEK
Stemtech CORP
8-K: Stemtech Announces Strategic Merger with Seacret Direct and Proposed Reverse Takeover of Eevia Health
Stemtech Corporation is set to merge with Seacret Direct and pursue a reverse takeover of Eevia Health, aiming to create a vertically integrated global health and wellness leader.
OTC.Pink
STEK
Stemtech CORP
8-K: Stemtech Corporation Announces Merger with Seacret Direct/Viago
Stemtech Corporation has entered into a merger agreement with Seacret Direct/Viago, valuing the acquisition at $32.5 million in Stemtech shares.
OTC.Pink
STEK
Stemtech CORP
8-K: Stemtech Corporation Changes Independent Auditor, Appoints Bush & Associates CPA
Stemtech Corporation has replaced Turner Stone LLP with Bush & Associates CPA as its independent registered public accounting firm, effective August 15, 2024.